A bovine myeloid antimicrobial peptide (BMAP-28) kills methicillin-resistant Staphylococcus aureus but promotes

Related Experiment Video

Updated: May 8, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

Shiaki Takagi1, Lanlan Bai, Tomomitsu Ozeki

  • 1Laboratory of Animal Microbiology, Department of Microbial Biotechnology, Graduate School of Agricultural Science, Tohoku University, Sendai, Miyagi, Japan.

Animal Science Journal = Nihon Chikusan Gakkaiho
|August 29, 2013
PubMed

Insights

Bovine myeloid antimicrobial peptide (BMAP-28) damages methicillin-resistant Staphylococcus aureus (MRSA) cell surfaces and binds to lipoteichoic acid. However, it may also promote bacterial adherence to host proteins at certain concentrations.

Area of Science:

  • Antimicrobial peptides
  • Bacterial cell surface interactions
  • Drug-resistant bacteria

Background:

  • Antimicrobial peptides (AMPs) are crucial in combating drug-resistant bacteria like methicillin-resistant Staphylococcus aureus (MRSA).
  • Bovine myeloid antimicrobial peptide (BMAP-28) is a cathelicidin AMP with potential therapeutic applications.

Purpose of the Study:

  • To investigate the activity of BMAP-28 against the bacterial cell surface of MRSA.
  • To explore BMAP-28's effects on Staphylococcus aureus adherence to extracellular matrix proteins.
  • To determine BMAP-28's interaction with lipoteichoic acid (LTA).

Main Methods:

  • Scanning probe microscopy to observe MRSA morphological changes induced by BMAP-28.
  • Adherence assays to evaluate BMAP-28's impact on S. aureus interaction with fibronectin and collagen.
  • Binding assays to confirm BMAP-28 interaction with S. aureus LTA.

Main Results:

  • BMAP-28 was observed to damage the cell surface of MRSA.
  • BMAP-28 demonstrated concentration-dependent effects on S. aureus adherence to fibronectin and collagen.
  • BMAP-28 was confirmed to bind with lipoteichoic acid (LTA) from S. aureus.

Conclusions:

  • BMAP-28 exhibits potential in damaging MRSA and interacting with its LTA.
  • The dual action of BMAP-28, including promoting adherence at certain concentrations, requires careful consideration for therapeutic use.
  • This study offers novel insights for developing AMPs as antibiotics against resistant bacteria.
Keywords:
adherenceantimicrobial peptidelipoteichoic acidmethicillin-resistant Staphylococcus aureus

More Related Videos

Biomimetic Materials to Characterize Bacteria-host Interactions12:22

Biomimetic Materials to Characterize Bacteria-host Interactions

Published on: November 16, 2015

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...